+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Antiproliferative effects of interferon alpha-2a in combination with all trans retinoic acid or cisplatin in human ovarian carcinoma cell lines



Antiproliferative effects of interferon alpha-2a in combination with all trans retinoic acid or cisplatin in human ovarian carcinoma cell lines



Proceedings of the American Association for Cancer Research Annual Meeting 37(0): 293




(PDF emailed within 1 workday: $29.90)

Accession: 030129924

Download citation: RISBibTeXText


Related references

Antiproliferative effects of alpha and beta interferon in combination with 5 fluorouracil cisplatin and cis and trans retinoic acid in two non small cell lung carcinoma cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 32: 228, 1991

Antiproliferative effects of interferons -alpha and -beta in combination with 5-fluorouracil, cisplatin, and cis- and trans-retinoic acid in three human lung carcinoma cell lines. Journal of Interferon Research 13(1): 25-32, 1993

Cytotoxic effect of interferon-alpha2a in combination with all-trans retinoic acid or cisplatin in human ovarian carcinoma cell lines. Anti-Cancer Drugs 9(3): 229-238, 1998

Modulation of cisplatin cytotoxicity by human recombinant interferon gamma and all trans-retinoic acid in four human ovarian cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 34(0): 295, 1993

Therapeutic effects of the combination of fenretinide and all-trans-retinoic acid and of the two retinoids with cisplatin in a human ovarian carcinoma xenograft and in a cisplatin-resistant sub-line. European Journal of Cancer 36(18): 2411-2419, 2000

Enhancement of cisplatin cytotoxicity by all trans retinoic acid on human ovarian carcinoma cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 36(0): 293, 1995

Phase II study of a combination of cisplatin, all-trans-retinoic acid and interferon-alpha in squamous cell carcinoma: clinical results and pharmacokinetics. Anticancer Research 21(2b): 1431-1437, 2001

The additive antiproliferative effect of all-trans retinoic acid and interferon-alpha2a on human cervical carcinoma cell lines is not associated with increased expression of retinoid receptors. Anti-Cancer Drugs 8(5): 522-528, 1997

Anti-tumour activity of all-trans retinoic acid alone and in combination with IFN alpha-2b and cisplatin in human testicular cancer cell lines. Annals of Hematology 67(SUPPL ): A26, 1993

Differential effects of all-trans retinoic acid and docosahexaenoic acid on cisplatin-induced cytotoxicity and apoptosis in cisplatin sensitive and resistant human embryonal carcinoma cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 37(0): 401, 1996

Multifactorial mechanism for the potentiation of cisplatin (CDDP) cytotoxicity by all-trans retinoic acid (ATRA) in human ovarian carcinoma cell lines. British Journal of Cancer 75(3): 333-340, 1997

Antiproliferative effects of all-trans retinoic acid and 9-cis retinoic acid on human lymphoid cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 34(0): 292, 1993

Radiation sensitivity of human squamous cell carcinoma cells in vitro is modulated by all-trans and 13-cis-retinoic acid in combination with interferon-alpha. International Journal of Radiation Oncology, Biology, Physics 45(4): 991-998, 1999

Response of four human ovarian carcinoma cell lines to all-trans retinoic acid: Relationship with induction of differentiation and retinoic acid receptor expression. International Journal of Cancer 56(5): 743-748, 1994

Retinoid receptors in murine and human bladder carcinoma lines and antiproliferative effects of all trans retinoic acid. Proceedings of the American Association for Cancer Research Annual Meeting 37(0): 273, 1996